Perrigo Company plc Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax
Perrigo Company plc (PRGO) reported Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax of $23.40 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax · last filed 2026-08-05
- Perrigo Company plc other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax for the quarter ending 2026-06-27 was $23.40M.
- Perrigo Company plc other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax for the quarter ending 2026-03-28 was $63.40M, a 45.75% increase year-over-year.
- Perrigo Company plc other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax for the quarter ending 2025-12-31 was -$2.70M, a 101.80% decline year-over-year.
- Perrigo Company plc other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax for the quarter ending 2025-09-27 was $18.20M.
- Perrigo Company plc other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax for fiscal 2025 was -$260.80M, a 284.31% decline from fiscal 2024.
- Perrigo Company plc other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax for fiscal 2024 was $141.50M.
- Perrigo Company plc other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax for fiscal 2020 was -$31.20M.
| Period end | Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax 3 month | Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax 6 month | Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax 9 month | Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax 12 month |
|---|---|---|---|---|
| 2026-06-27 | $23.40M 10-Q · filed 2026-08-05 | $86.80M 10-Q · filed 2026-08-05 | $84.10M derived: sum of 3 quarters · filed 2026-08-05 | $102.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $63.40M 10-Q · filed 2026-05-06 | $60.70M derived: sum of 2 quarters · filed 2026-05-06 | $78.90M derived: sum of 3 quarters · filed 2026-05-06 | -$121.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.50M derived: sum of 2 quarters · filed 2026-02-26 | -$184.50M derived: sum of 3 quarters · filed 2026-08-05 | -$260.80M 10-K · filed 2026-02-26 |
| 2025-09-27 | $18.20M 10-Q · filed 2025-11-05 | -$181.80M derived: sum of 2 quarters · filed 2026-08-05 | -$258.10M 10-Q · filed 2025-11-05 | $11.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | -$200.00M 10-Q · filed 2026-08-05 | -$276.30M 10-Q · filed 2026-08-05 | -$6.60M derived: sum of 3 quarters · filed 2026-08-05 | -$81.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | $43.50M 10-Q · filed 2026-05-06 | $193.40M derived: sum of 2 quarters · filed 2026-05-06 | $118.70M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $149.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $75.20M derived: sum of 2 quarters · filed 2026-02-26 | $141.50M 10-K · filed 2026-02-26 | |
| 2024-09-28 | -$74.70M 10-Q · filed 2025-11-05 | -$8.40M 10-Q · filed 2025-11-05 | ||
| 2020-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$13.40M derived: sum of 2 quarters · filed 2023-02-28 | -$16.30M derived: sum of 3 quarters · filed 2023-02-28 | -$31.20M 10-K · filed 2023-02-28 |
| 2020-09-26 | -$12.00M 10-Q · filed 2021-11-12 | -$14.90M derived: sum of 2 quarters · filed 2021-11-12 | -$29.80M 10-Q · filed 2021-11-12 | |
| 2020-06-27 | -$2.90M 10-Q · filed 2020-08-05 | -$17.90M 10-Q · filed 2020-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |